← Open Payments lookup

TARA PETERSON: Open Payments

NPI 1235108457 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$420 in 22 payments from 10 companies in 2025. Trend: 2023 $454 · 2024 $616 · 2025 $420

Food & beverage: $420
CompanyPaymentsAmount
Janssen Biotech, Inc.4$78
Madrigal Pharmaceuticals3$61
ABBVIE INC.3$59
Takeda Pharmaceuticals U.S.A., Inc.2$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$43
GENZYME CORPORATION1$35
Phathom Pharmaceuticals, Inc.4$33
Aimmune Therapeutics, Inc.1$28
Intercept Pharmaceuticals, Inc.1$18
PFIZER INC.1$16

Products named: TREMFYA, REZDIFFRA, XIFAXAN, DUPIXENT, VOQUEZNA, GATTEX, ZENPEP, RINVOQ.

Industry payments across NE — which companies pay providers there.